News

Pharmaceutical Technology33m
FDA approves GSK’s prefilled syringe presentation of Shingrix
The FDA has approved GSK's Shingrix vaccine (recombinant zoster vaccine or RZV) in a prefilled syringe presentation to prevent shingles.
FDA votes against overall benefit/risk profile of GSK's multiple myeloma candidate at proposed dosage
Drugmaker GSK said on Friday that the US Food and Drug Administration's Oncologic Drugs Advisory Committee had voted against ...
Fierce Biotech2d
GSK telegraphs 'very limited number' of job cuts amid R&D investment spree
With GSK kicking its research and development engine into high gear in recent years, a shuffling of the scientific priorities ...
GSK slides Tuesday, underperforms market
GSK PLC closed 16.45% short of its 52-week high of £16.79, which the company reached on September 9th.
GSK's Linerixibat Poised To Address Substantial Unmet Need For The Treatment Of Pruritus Associated With Primary Biliary Cholangitis, According To Spherix Global Insights
Despite new market entrants in the form of Gilead's Livdelzi and Ipsen's Iqirvo, US gastroenterologists report nearly half of PBC patients suffer fro ...
GlobalData on MSN1d
GSK’s Blenrep US comeback hindered by eye safety concerns
FDA reviewers have identified high rates of ocular toxicity as GSK looks to place its blood cancer drug back on the market.
GSK falls Friday, underperforms market
GSK PLC closed 16.09% below its 52-week high of £16.79, which the company achieved on September 9th.
GSK seeks FDA nod for expanded use of RSV vaccine in adults
British drugmaker GSK said on Monday it had submitted an application to the U.S. Food and Drug Administration to extend the ...